https://www.selleckchem.com/pr....oducts/troglitazone-
Recently a new continuous non-invasive cardiac output measurement, bioreactance, has become available. Bioreactance measurement of cardiac output has been shown to correlate with left ventricular output detected by echocardiography in healthy term and preterm neonates. Our aim was to correlate cardiac output measurements by bioreactance in the first 48h of life with adverse outcomes attributable to hypoperfusion (peri/intraventricular haemorrhage (PIVH) and/or necrotising enterocolitis (NEC)) in the cohort of extremely prete
Aimer
Commentaire
Partagez
